Literature DB >> 21527249

Co-repressor activity of scaffold attachment factor B1 requires sumoylation.

Jason P Garee1, Rene Meyer, Steffi Oesterreich.   

Abstract

Sumoylation is an emerging modification associated with a variety of cellular processes including the regulation of transcriptional activities of nuclear receptors and their coregulators. As SUMO modifications are often associated with transcriptional repression, we examined if sumoylation was involved in modulation of the transcriptional repressive activity of scaffold attachment factor B1. Here we show that SAFB1 is modified by both the SUMO1 and SUMO2/3 family of proteins, on lysine's K231 and K294. Further, we demonstrate that SAFB1 can interact with PIAS1, a SUMO E3 ligase which mediates SAFB1 sumoylation. Additionally, SENP1 was identified as the enzyme desumoylating SAFB1. Mutation of the SAFB1 sumoylation sites lead to a loss of transcriptional repression, at least in part due to decreased interaction with HDAC3, a known transcriptional repressor and SAFB1 binding partner. In summary, the transcriptional repressor SAFB1 is modified by both SUMO1 and SUMO2/3, and this modification is necessary for its full repressive activity.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21527249      PMCID: PMC3955274          DOI: 10.1016/j.bbrc.2011.04.040

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  18 in total

Review 1.  Something about SUMO inhibits transcription.

Authors:  Grace Gill
Journal:  Curr Opin Genet Dev       Date:  2005-10       Impact factor: 5.578

Review 2.  Modification of proteins by ubiquitin and ubiquitin-like proteins.

Authors:  Oliver Kerscher; Rachael Felberbaum; Mark Hochstrasser
Journal:  Annu Rev Cell Dev Biol       Date:  2006       Impact factor: 13.827

3.  Scaffold attachment factor B1 directly interacts with nuclear receptors in living cells and represses transcriptional activity.

Authors:  M-B Debril; L Dubuquoy; J-N Feige; W Wahli; B Desvergne; J Auwerx; L Gelman
Journal:  J Mol Endocrinol       Date:  2005-12       Impact factor: 5.098

Review 4.  Modification in reverse: the SUMO proteases.

Authors:  Debaditya Mukhopadhyay; Mary Dasso
Journal:  Trends Biochem Sci       Date:  2007-05-17       Impact factor: 13.807

Review 5.  Concepts in sumoylation: a decade on.

Authors:  Ruth Geiss-Friedlander; Frauke Melchior
Journal:  Nat Rev Mol Cell Biol       Date:  2007-12       Impact factor: 94.444

6.  Scaffold attachment factor SAFB1 suppresses estrogen receptor alpha-mediated transcription in part via interaction with nuclear receptor corepressor.

Authors:  Shiming Jiang; Rene Meyer; Kaiyan Kang; C Kent Osborne; Jiemin Wong; Steffi Oesterreich
Journal:  Mol Endocrinol       Date:  2005-09-29

7.  Structure-function analysis of the estrogen receptor alpha corepressor scaffold attachment factor-B1: identification of a potent transcriptional repression domain.

Authors:  Steven M Townson; Kaiyan Kang; Adrian V Lee; Steffi Oesterreich
Journal:  J Biol Chem       Date:  2004-04-05       Impact factor: 5.157

8.  A novel hnRNP protein (HAP/SAF-B) enters a subset of hnRNP complexes and relocates in nuclear granules in response to heat shock.

Authors:  F Weighardt; F Cobianchi; L Cartegni; I Chiodi; A Villa; S Riva; G Biamonti
Journal:  J Cell Sci       Date:  1999-05       Impact factor: 5.285

9.  A novel member of the SAF (scaffold attachment factor)-box protein family inhibits gene expression and induces apoptosis.

Authors:  Ching Wan Chan; Youn-Bok Lee; James Uney; Andrea Flynn; Jonathan H Tobias; Michael Norman
Journal:  Biochem J       Date:  2007-11-01       Impact factor: 3.857

10.  SAFB re-distribution marks steps of the apoptotic process.

Authors:  Youn-Bok Lee; Shane Colley; Michel Norman; Giuseppe Biamonti; James B Uney
Journal:  Exp Cell Res       Date:  2007-07-06       Impact factor: 3.905

View more
  7 in total

1.  Multiple crosstalks between mRNA biogenesis and SUMO.

Authors:  Jérôme O Rouvière; Marie-Claude Geoffroy; Benoit Palancade
Journal:  Chromosoma       Date:  2013-04-14       Impact factor: 4.316

2.  Therapeutic Targeting of Nemo-like Kinase in Primary and Acquired Endocrine-resistant Breast Cancer.

Authors:  Xian Wang; Jamunarani Veeraraghavan; Chia-Chia Liu; Xixi Cao; Lanfang Qin; Jin-Ah Kim; Ying Tan; Suet Kee Loo; Yiheng Hu; Ling Lin; Sanghoon Lee; Martin J Shea; Tamika Mitchell; Shunqiang Li; Matthew J Ellis; Susan G Hilsenbeck; Rachel Schiff; Xiao-Song Wang
Journal:  Clin Cancer Res       Date:  2021-02-04       Impact factor: 12.531

3.  Scaffold attachment factor B2 (SAFB2)-null mice reveal non-redundant functions of SAFB2 compared with its paralog, SAFB1.

Authors:  Shiming Jiang; Tiffany A Katz; Jason P Garee; Francesco J DeMayo; Adrian V Lee; Steffi Oesterreich
Journal:  Dis Model Mech       Date:  2015-06-18       Impact factor: 5.758

4.  The chromatin scaffold protein SAFB1 localizes SUMO-1 to the promoters of ribosomal protein genes to facilitate transcription initiation and splicing.

Authors:  Hui-wen Liu; Tapahsama Banerjee; Xiaoyan Guan; Michael A Freitas; Jeffrey D Parvin
Journal:  Nucleic Acids Res       Date:  2015-03-23       Impact factor: 16.971

5.  Activated SUMOylation restricts MHC class I antigen presentation to confer immune evasion in cancer.

Authors:  Uta M Demel; Marlitt Böger; Schayan Yousefian; Corinna Grunert; Le Zhang; Paul W Hotz; Adrian Gottschlich; Hazal Köse; Konstandina Isaakidis; Dominik Vonficht; Florian Grünschläger; Elena Rohleder; Kristina Wagner; Judith Dönig; Veronika Igl; Bernadette Brzezicha; Francis Baumgartner; Stefan Habringer; Jens Löber; Björn Chapuy; Carl Weidinger; Sebastian Kobold; Simon Haas; Antonia B Busse; Stefan Müller; Matthias Wirth; Markus Schick; Ulrich Keller
Journal:  J Clin Invest       Date:  2022-05-02       Impact factor: 19.456

6.  The Scaffold attachment factor b1 (Safb1) regulates myogenic differentiation by facilitating the transition of myogenic gene chromatin from a repressed to an activated state.

Authors:  J Manuel Hernández-Hernández; Chandrashekara Mallappa; Brian T Nasipak; Steffi Oesterreich; Anthony N Imbalzano
Journal:  Nucleic Acids Res       Date:  2013-04-22       Impact factor: 16.971

7.  The BTB-containing protein Kctd15 is SUMOylated in vivo.

Authors:  Valeria E Zarelli; Igor B Dawid
Journal:  PLoS One       Date:  2013-09-24       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.